Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation

NCT00974272 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

39

Enrollment

FED

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Impaired Glucose Tolerance

Interventions

DRUG: Exenatide
OTHER: Normal Saline

Sponsor

Carl T. Hayden VA Medical Center